These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23698113)

  • 1. Insulin directly stimulates VEGF-A production in the glomerular podocyte.
    Hale LJ; Hurcombe J; Lay A; Santamaría B; Valverde AM; Saleem MA; Mathieson PW; Welsh GI; Coward RJ
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F182-8. PubMed ID: 23698113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
    Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
    PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
    Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
    Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.
    Sison K; Eremina V; Baelde H; Min W; Hirashima M; Fantus IG; Quaggin SE
    J Am Soc Nephrol; 2010 Oct; 21(10):1691-701. PubMed ID: 20688931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.
    Datta K; Li J; Karumanchi SA; Wang E; Rondeau E; Mukhopadhyay D
    Kidney Int; 2004 Oct; 66(4):1471-8. PubMed ID: 15458440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
    Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
    Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
    Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
    J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.
    Veron D; Aggarwal PK; Velazquez H; Kashgarian M; Moeckel G; Tufro A
    J Am Soc Nephrol; 2014 Aug; 25(8):1814-24. PubMed ID: 24578128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular Injury.
    Stevens M; Neal CR; Salmon AHJ; Bates DO; Harper SJ; Oltean S
    Nephron; 2018; 139(1):51-62. PubMed ID: 29393270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
    Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
    Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
    Eremina V; Cui S; Gerber H; Ferrara N; Haigh J; Nagy A; Ema M; Rossant J; Jothy S; Miner JH; Quaggin SE
    J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
    Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
    Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
    FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BECLIN1 Is Essential for Podocyte Secretory Pathways Mediating VEGF Secretion and Podocyte-Endothelial Crosstalk.
    Bork T; Liang W; Kretz O; Lagies S; Yamahara K; Hernando-Erhard C; Helmstädter M; Schell C; Kammerer B; Huber TB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 19. An In Vitro Method to Analyze Glucose Uptake in Podocytes.
    Lay AC; Coward RJ
    Methods Mol Biol; 2020; 2067():139-143. PubMed ID: 31701450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
    Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
    Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.